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Abstract   
 
The government has worked hard in an effort to eradicate tuberculosis by forming a 
program Temukan Obati Sampai Sembuh Tuberculosis (TOSS TBC) to free the 
Indonesian people from Tuberculosis in 2025. Directly Observed Treatment Short-course 
(DOTS) strategy treatment is the best effort in treating TB, but other problems arise 
related to the treatment, one of which is the emergence of resistance to Obat Anti 
Tuberculosis  (OAT). Detection of the occurrence of resistance of Mycobacterium 
tuberculosis from sputum specimens of tuberculosis patients in BALKESMAS Semarang 
used a non-experimental cross-sectional design with a non-intervention approach survey 
method. Sputum samples were from TB patients who did not convert during treatment. 
Percentage of culture results from 9 patients was 33.3.  DST test from sensitive first-line 
OAT samples, morphological and size changes (1.82 - 1.87 µm) shows that first-line drugs 
were still effective for treatment inpatients who took part in this study. Samples 
conducted as a study can still be treated with first-line drugs. Patients must be obedient 
to take medication for  speed healing 
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1. Introduction 
Tuberculosis cases in Central Java in 2017 
were noted 42,272 cases out of a total population 
of 34,257,865 with positive Acid-fast bacilli (AFB) 
cases of 18,248 (10,614 men and 7,734 women).   
The number of Case natification rates (CNR) was 
123 and the number of Positive AFB was 53. 
Positive pulmonary tuberculosis coverage had 
cured 11,758 or 93.07% -- 876 or 6.93% with 
complete treatment.   The treatment success was  
12,634 or 72.84% (Ministry of Health, RI, 2018).  
The government has worked  hard in an 
effort to eradicate tuberculosis by forming a 
program Temukan Obati Samapai Sembuh 
Tuberculosis (TOSS TBC) to free the Indonesian 
people from Tuberculosis in 2025. Directly 
Observed Treatment Short-course (DOTS) 
strategy treatment is the best effort in treating 
TB, but other problems arise related to treatment, 
one of which is the emergence of resistance to 
Obat Anti Tuberculosis  (OAT). 
The standard of treatment can be achieved 
with about 98% recovery and less than 5% 
relapse if Isoniazid (INH), rifampicin (RMP), 
Ptrazinamide (PZA) and Entambutol (EMB) 
drugs are treated for 6 months. If the four drugs 
are reduced, RMP and INH will recur after 2 
months and treatment will last longer (Zang and 
Yew, 2009).  
Irregular drug exposure will cause 
spontaneous resistance because Mycobacterium 
tuberculosis has a wall layer that is resistant to 
acids. Morphologically, the Mycobacterium 
tuberculosis exposed to the anti-TB drug INH 
will experience changes in size and shape 
(Widodo, 2016). 
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2. Method 
This research was carried out in the 
Microbiology Laboratory of Campus III, 
Semarang Ministry of Health Polytechnic, 
Semarang Community Health Center and Health 
Laboratory and Testing Center of the Central 
Java Medical Center. This study used a non-
experimental cross-sectional design with no 
descriptive analytic intervention that takes 
phlegm specimens from patients suffering from 
tuberculosis. The number of samples was 9 
specimens with inclusion criteria not to be 
converted for 2 months, microscopic 
examination, culture test, and Mycobacterium 
tuberculosis drug sensitivity test (DST). 
 
3. Result and Discussion 
Sputum samples obtained from Semarang 
Community Health Center (BALKESMAS 
Semarang) were carried out with microscopic 
examination directly by making sedian 
preparations measuring 3 x 2 cm and then 
continued with Ziehl Neelsen staining and 
finally they were cultured on Jensen lowenstein 
media for 6-8 weeks at 37ºC. 
 
Table 1. Results of Ziehl Neelsen Stain and 
Culture  
 
No Sample 
code 
ZN 
Stain 
Culture 
results 
PNB Niacin Catalase 
heat 
DST 
INH 
test 
1 X01 N NGR - - - - 
2 X02 N NGR - - - - 
3 X03 N NGR - - - - 
4 X04 N NGR - - - - 
5 X05 N 1 C N P N S 
6 X06 N NGR - - - - 
7 X07 N 2  C N P N S 
8 X08 1 + 5  C N P N S 
9 X09 N NGR - - - - 
N : Negative , P : Positive , C : Colony,              
NGR: No Growth  
 
The results in the table show that during 
intensive treatment and insertion, if the patient 
did not convert ZN's direct sputum examination 
to positive results, there is a possibility that there 
were still surviving M. tuberculosis in the 
sputum of the patients undergoing treatment 
therapy. The Percentage of culture results from 
nine patients was 33.3% of the patients who had 
sputum with M. tuberculosis which can grow in 
LJ media. 
 
a. Size of M. tuberculosis 
The morphological variations of M. 
tuberculosis are classified into two categories 
that are often encountered in the exponential 
phase with the growth of stems with variations 
in form V, Y or branching.  When under stress 
conditions or unfavorable environments, they  
are round, oval, or crooked to resemble the letter 
L (Velayati and Farnia, 2012; Daniel, 2009). 
 
Table 2.  size and morphology damge  
 
 
The results of the table show that the 
percentage of growth rates indicates that M. 
tuberculosis from pure iculture had more growth 
compared to samples from sputum of TB 
patients who did not convert treatment. The size 
decreased due to exposure to the drug so that the 
size of M. tuberculosis underwent this shortening 
because metabolic rates in response to exposure 
(stress) tended to be favorable for continuous 
growth under conditions of nutrient deficiencies 
or other factors that could cause imbalances in 
cellular metabolism (Baek et al, 2011). 
The size of M. Tuberculosis shrinks when it 
is compared with pure culture. When 
experiencing treatment, the average size is 1.82 - 
1.87 µm while the pure culture is 2.08 µm. 
 
b. Morphology of M. tuberculosis with ZN 
staining 
Observations using digital cameras are used 
to improve the image by adjusting the 
brightness, contrast and color of the image so 
that the pixel value is good (Mukti and Kale, 
2011). 
 
Sample    Growth 
Colony 
Average 
Size 
Normal 
Percentage 
(%) 
Abnormal 
Percentage 
(%) 
H37Rv 300 2.08 100 % 0 
X05 1 1.82 0 100 % 
X07 2 1.87 0 100 % 
X08 5 1.85 0 100  % 
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Figure 1.  Morphology of M. tuberculosis with ZN 
staining A. treatment without conversion, B 
.culture wheel tap H37Rv 
 
Figure A shows M. tuberculosis of patients 
who had undergone treatment without 
conversion showing that the bacteria was 
slightly tingling, slightly oval  
Figure B shows M. tuberculosis from pure 
culture which had not been exposed to long rod 
bacterial OAT. 
 
c. DST test (drug susceptibility test) M. 
tuberculosis 
Examination of culture with the drug 
susceptibility test from 9 cultures carried out all 
the results of sensitive shows can be seen from 
the table below. 
 
Table 3.  DST test (drug susceptibility test) M. 
tuberculosis 
 
 _ =indicates no growth 
S = indicates sensitive drug 
 
The results of the examination in the table 
show that all samples grown from culture results 
were still sensitive to first-line OAT with 
concentrations of streptomycin 4 mg/l, INH 0.2 
mg/l, Rifampicin 40 mg/l, Ethambutol 2 mg/l, 
so that the first line drug can still be used for 
treatment. 
4. Conclusion and Sugestion 
The results of examination of patients who 
were not converted during OAT treatment of TB 
disease from 9 samples indicated that 3 samples 
grew at the time of culture; and DST test was 
sensitive for all morphological changes of M. 
tuberculosis during the treatment process. 
The research was carried out by considering 
factors related to medication adherence and 
more sample coverage. 
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